Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.
- DOI
- 10.1016/j.ygyno.2018.12.009
- Published
- 2019 Mar
- Container
- Gynecologic oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ygyno.2018.12.009,
title = {Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.},
author = {Fabbro M and Moore KN and Dørum A and Tinker AV and Mahner S and Bover I and Banerjee S and Tognon G and Goffin F and Shapira-Frommer R and Wenham RM and Hellman K and Provencher D and Harter P and Vázquez IP and Follana P and Pineda MJ and Mirza MR and Hazard SJ and Matulonis UA},
year = {2019},
journal = {Gynecologic oncology},
doi = {10.1016/j.ygyno.2018.12.009},
url = {https://doi.org/10.1016/j.ygyno.2018.12.009}
}RIS
TY - JOUR TI - Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial. AU - Fabbro M AU - Moore KN AU - Dørum A AU - Tinker AV AU - Mahner S AU - Bover I AU - Banerjee S AU - Tognon G AU - Goffin F AU - Shapira-Frommer R AU - Wenham RM AU - Hellman K AU - Provencher D AU - Harter P AU - Vázquez IP AU - Follana P AU - Pineda MJ AU - Mirza MR AU - Hazard SJ AU - Matulonis UA PY - 2019 JO - Gynecologic oncology DO - 10.1016/j.ygyno.2018.12.009 UR - https://doi.org/10.1016/j.ygyno.2018.12.009 ER -
APA
M, F., KN, M., A, D., AV, T., S, M., I, B., S, B., G, T., F, G., R, S., RM, W., K, H., D, P., P, H., IP, V., P, F., MJ, P., MR, M., SJ, H., & UA, M. (2019). Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial.. Gynecologic oncology. https://doi.org/10.1016/j.ygyno.2018.12.009
Source records
- pubmed · retrieved 2026-09-25T14:22:21.070Z